fundraising >
Loading...
Loading investors...
16,382 investors
16,382 investors |
Geography | Checks | Stages | Lead | Investment thesis | Value add | Typical terms | Socials | Reply rate | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | Blockchange Ventur... VC firm |  Canada Colombia Germany Hong Kong Israel Japan Switzerland USA | N/A | 2. Prototype 3. Early Revenue4. Scaling | Sometimes | We invest in blockchain. |
|
Send email
| |||
 | 99 Tartans | Canada USA | N/A | 2. Prototype 3. Early Revenue4. Scaling | Never | We invest in Carnegie Mellon founders. |
|
Send email
| |||
 | Business Valley |  Egypt Saudi Arabia USA | N/A | 2. Prototype 3. Early Revenue | Sometimes | We invest as an incubator and business angels network. |
|
Send email
| |||
 | Align Capital | USA | N/A | 4. Scaling | Sometimes | We invest in various industries. |
|
Send email
| |||
 | Waldencast |  Brazil UK USA | N/A | 3. Early Revenue 4. Scaling | Sometimes | We invest in early-stage beauty and wellness brands. | Global beauty management expertise, operational and supply-chain infrastructure, logistics and resource-scaling support, enterprise-level operational capabilities, market responsiveness, and preservation of founder autonomy and brand independence.
|
|
Send email
| ||
Get Fin free for 1 year with OpenVCUse code "OpenVC". Conditions apply. |
|||||||||||
 | Norrsken22 | Hong Kong Nigeria South Africa USA | N/A | 4. Scaling 5. Growth3. Early Revenue | Sometimes | We invest in technology companies and exceptional entrepreneurs. |
|
Send email
| |||
 | Aquasourca |  Belgium France | N/A | 4. Scaling 3. Early Revenue | Sometimes | We invest in various sectors. |
|
| |||
 | Australian Medical... |  Australia Singapore USA | N/A | 2. Prototype 3. Early Revenue | Sometimes | We invest in healthcare opportunities. |
|
Send email
| |||
 | Calvert Social Ven... VC firm | USA | N/A | 3. Early Revenue 4. Scaling5. Growth | Never | We invest in government and property-related ventures. |
|
Send email
| |||
 | Rumbo Ventures VC firm |  Mexico Norway UK USA | N/A | 2. Prototype 3. Early Revenue | Never | We invest in early-stage climate technology companies, specifically within agtech, construction, energy, food and beverage, green tech, industrial, and software sectors. |
|
Send email
| |||
 | Muse Capital VC firm | Canada China Denmark Mexico UK USA | max. $1.5M | 2. Prototype 3. Early Revenue4. Scaling5. Growth | Sometimes | We invest in entrepreneurs disrupting the consumer sector. |
|
Send email
| |||
 | Clean Energy Finan... VC firm | Australia UK USA | N/A | 2. Prototype 3. Early Revenue4. Scaling5. Growth | Sometimes | We invest in the clean energy sector. |
|
Send email
| |||
 | Red Bear Angels | USA | N/A | 3. Early Revenue 4. Scaling | Never | We invest in sector-agnostic promising new companies. |
|
Send email
| |||
 | Aarin Capital VC firm |  India Singapore USA | N/A | 3. Early Revenue 4. Scaling5. Growth | Sometimes | We invest in wealth management. |
|
Send email
| |||
 | Brooks Hill Partne... VC firm | Germany USA | N/A | 2. Prototype 3. Early Revenue | Never | We invest in early-stage, technology-enabled healthcare companies. |
|
Send email
| |||
 | MPG Equity Partner... | USA | N/A | 3. Early Revenue | Never | We invest in businesses requiring ownership transition, focusing on wealth management. |
|
Send email
| |||
 | Fortune Venture Ca... VC firm | China Japan USA | N/A | 3. Early Revenue 4. Scaling5. Growth6. Pre-IPO | Sometimes | We invest in manufacturing and telecommunications. |
|
Send email
| |||
 | Fidelity Internati... VC firm | Australia China France Hong Kong India Japan Malaysia Singapore UK USA | N/A | 4. Scaling 5. Growth6. Pre-IPO3. Early Revenue | Sometimes | We invest in solutions for financial management and retirement planning. |
|
Send email
| |||
 | Institute of Educa... Public fund | USA | N/A | 3. Early Revenue | Sometimes | We invest in initiatives related to education research, evaluation, and data. |
|
Send email
| |||
 | Tachyon Ventures VC firm | USA | N/A | 3. Early Revenue 4. Scaling5. Growth | Never | We invest in early-stage life sciences ventures, including medicine, biotech, and bioengineering. |
|
Send email
| |||